Trial Profile
Effect of fingolimod in imparing or affecting T-cells release and function from thymus in multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 28 Sep 2016 New trial record